Is Narayana Hrudayalaya the Best Stock in Its Sector? A Look at the Numbers
- October 14, 2026
- Posted by: Harsh Piplani
- Category: Market
Narayana Hrudayalaya CMP Rs 1,695 (14 Oct 2026). Market cap Rs 34,465 Cr. ROE 17.76%. P/E 42.20x versus Industry P/E 61.61x.
Quick Answer
Narayana Hrudayalaya is one of the names investors compare when screening the Healthcare sector, built on a 17.76% return on equity and a P/E of 42.20x against an Industry P/E of 61.61x. Whether Narayana Hrudayalaya is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.
Is Narayana Hrudayalaya the best stock in its sector? The stock trades on the NSE at Rs 1,695 as of 14 October 2026, within its 52-week range of Rs 1,589.00 to Rs 2,093.30. Narayana Hrudayalaya Ltd, headquartered in Bengaluru and operating as Narayana Health, runs a network of multi-speciality hospitals, with a strong presence in cardiac care.
Narayana Hrudayalaya sits in the Healthcare sector, and its 17.76% ROE and 42.20x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.
Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers
Click Here – Get Free Investment Predictions
About Narayana Hrudayalaya
Narayana Hrudayalaya Ltd, headquartered in Bengaluru and operating as Narayana Health, runs a network of multi-speciality hospitals, with a strong presence in cardiac care. Its hospitals are spread across several Indian cities, and it also operates a hospital in the Cayman Islands. The stock trades about 19 percent below its 52-week high and about 7 percent above its 52-week low. At a market capitalisation of Rs 34,465 Cr, it is tracked as part of the Healthcare sector on Univest.
Is Narayana Hrudayalaya the Best Stock in Its Sector?
Narayana Hrudayalaya makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, combining a 17.76% ROE with a 42.20x P/E against the sector’s 61.61x Industry P/E. Narayana Hrudayalaya’s 42.20x P/E is below the 61.61x Industry P/E, Max Healthcare Institute at 57.68x and Fortis Healthcare at 53.31x, and its 17.76% ROE is higher than Max Healthcare Institute at 13.42% and Fortis Healthcare at 10.53%, though its debt to equity ratio of 1.29 is well above both.
| Metric | Narayana Hrudayalaya |
|---|---|
| CMP (NSE) | Rs 1,694.80 |
| 52-Week High / Low | Rs 2,093.30 / Rs 1,589.00 |
| Market Cap | Rs 34,465 Cr |
| P/E (TTM) vs Industry P/E | 42.20x vs 61.61x |
| P/B | 7.59 |
| ROE | 17.76% |
| EPS (TTM) | Rs 39.96 |
| Dividend Yield | 0.27% |
| Debt to Equity | 1.29 |
Compare Narayana Hrudayalaya Against Other Healthcare Sector Stocks
How Narayana Hrudayalaya Compares Against Its Healthcare Sector Peers
The table below sets Narayana Hrudayalaya against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.
| Company | Market Cap (Rs Cr) | P/E | ROE | Debt to Equity |
|---|---|---|---|---|
| Narayana Hrudayalaya | 34,465 | 42.20 | 17.76% | 1.29 |
| Max Healthcare Institute | 84,036 | 57.68 | 13.42% | 0.32 |
| Fortis Healthcare | 57,075 | 53.31 | 10.53% | 0.35 |
| Peer average (2 companies) | – | 55.50 | 11.97% | 0.33 |
Against this peer set, Narayana Hrudayalaya’s 17.76% ROE is above the 11.97% peer average, and its P/E of 42.20x runs below the peer average of 55.50x. Narayana Hrudayalaya’s 42.20x P/E is below the 61.61x Industry P/E, Max Healthcare Institute at 57.68x and Fortis Healthcare at 53.31x, and its 17.76% ROE is higher than Max Healthcare Institute at 13.42% and Fortis Healthcare at 10.53%, though its debt to equity ratio of 1.29 is well above both.
What Makes Narayana Hrudayalaya Worth Watching in Healthcare
- Valuation discount: A 42.20x P/E is lower than the 61.61x Industry P/E, Max Healthcare Institute at 57.68x and Fortis Healthcare at 53.31x.
- Strong returns: A 17.76% ROE is higher than Max Healthcare Institute at 13.42% and Fortis Healthcare at 10.53%.
- Leverage: A debt to equity ratio of 1.29 is well above Max Healthcare Institute at 0.32 and Fortis Healthcare at 0.35.
Narayana Hrudayalaya Valuation: Is It Justified?
Narayana Hrudayalaya’s 42.20x P/E is below the 61.61x Industry P/E, Max Healthcare Institute at 57.68x and Fortis Healthcare at 53.31x, and its 17.76% ROE is higher than Max Healthcare Institute at 13.42% and Fortis Healthcare at 10.53%, though its debt to equity ratio of 1.29 is well above both. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.
Also read – Is Alkem Laboratories the Best Stock in Its Sector? A Look at the Numbers
Download the Univest iOS App or Univest Android App to track Narayana Hrudayalaya and other Healthcare sector stocks.
How to Track Narayana Hrudayalaya Before You Invest
Before deciding whether Narayana Hrudayalaya deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.
- Open the Univest Screener and search for Narayana Hrudayalaya to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
- Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
- Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
- Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.
Conclusion
Narayana Hrudayalaya earns a place in the best stock in its sector conversation on the strength of a 17.76% ROE and a P/E of 42.20x against a 61.61x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Is Narayana Hrudayalaya the best stock in its sector?
Ans. Narayana Hrudayalaya has a 17.76% ROE and trades at 42.20x P/E against a 61.61x Industry P/E, and compares above the peer average ROE of 11.97% in this article’s named comparison, so the answer depends on what an investor is prioritising.
What is the current share price of Narayana Hrudayalaya?
Ans. Narayana Hrudayalaya was trading at Rs 1,694.80 on the NSE as of 14 October 2026, within its 52-week range of Rs 1,589.00 to Rs 2,093.30.
What sector does Narayana Hrudayalaya belong to?
Ans. Narayana Hrudayalaya is classified under the Healthcare sector on Univest.
How does Narayana Hrudayalaya compare to its sector peers on P/E?
Ans. Narayana Hrudayalaya’s P/E of 42.20x is below the 55.50x average of the 2 named peers compared in this article.
What is Narayana Hrudayalaya’s return on equity?
Ans. Narayana Hrudayalaya reported a return on equity of 17.76%, which is above the 11.97% average of its named peers in this comparison.
Should I invest in Narayana Hrudayalaya based on its sector position?
Ans. Narayana Hrudayalaya’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.
{“@context”: “https://schema.org”, “@type”: “FAQPage”, “mainEntity”: [{“@type”: “Question”, “name”: “Is Narayana Hrudayalaya the best stock in its sector?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Narayana Hrudayalaya has a 17.76% ROE and trades at 42.20x P/E against a 61.61x Industry P/E, and compares above the peer average ROE of 11.97% in this article’s named comparison, so the answer depends on what an investor is prioritising.”}}, {“@type”: “Question”, “name”: “What is the current share price of Narayana Hrudayalaya?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Narayana Hrudayalaya was trading at Rs 1,694.80 on the NSE as of 14 October 2026, within its 52-week range of Rs 1,589.00 to Rs 2,093.30.”}}, {“@type”: “Question”, “name”: “What sector does Narayana Hrudayalaya belong to?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Narayana Hrudayalaya is classified under the Healthcare sector on Univest.”}}, {“@type”: “Question”, “name”: “How does Narayana Hrudayalaya compare to its sector peers on P/E?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Narayana Hrudayalaya’s P/E of 42.20x is below the 55.50x average of the 2 named peers compared in this article.”}}, {“@type”: “Question”, “name”: “What is Narayana Hrudayalaya’s return on equity?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Narayana Hrudayalaya reported a return on equity of 17.76%, which is above the 11.97% average of its named peers in this comparison.”}}, {“@type”: “Question”, “name”: “Should I invest in Narayana Hrudayalaya based on its sector position?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Narayana Hrudayalaya’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.”}}]}
